Proteomics-based phenotypic classification of non-smallcell lung cancer

被引:0
|
作者
Berkovska, O. [1 ]
Mermelekas, G. [1 ]
Orre, L. [1 ]
Lehtio, J. [1 ]
机构
[1] Karolinska Inst, Oncol Pathol, Stockholm, Sweden
关键词
D O I
10.1016/j.annonc.2023.09.1292
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2264P
引用
收藏
页码:S1163 / S1164
页数:2
相关论文
共 50 条
  • [1] Atezolizumab in previously treated non-smallcell lung cancer patients
    Serino, Mariana
    Santos, Vanessa
    Araujo, David
    Novais-Bastos, Helder
    Magalhaes, Adriana
    Fernandes, Gabriela
    Queiroga, Henrique
    Hespanhol, Venceslau
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [2] FoxM1 mediated resistance to gefitinib in non-smallcell lung cancer cells
    Nuo Xu
    Xin Zhang
    Xun Wang
    Hai-yan Ge
    Xiao-ying Wang
    David Garfield
    Ping Yang
    Yuan-lin Song
    Chun-xue Bai
    Acta Pharmacologica Sinica, 2012, 33 : 675 - 681
  • [3] Stereotactic Radiation for Ultra-Central Non-SmallCell Lung Cancer: A Safety and EfficacyTrial(SUNSET)
    Giuliani, M. E.
    Filion, E. J.
    Faria, S.
    Kundapur, V.
    Vu, T. T. T.
    Lok, B. H.
    Raman, S.
    Bahig, H.
    Laba, J. M.
    Lang, P.
    Louie, A.
    Hope, A.
    Rodrigues, G.
    Bezjak, A.
    Campeau, M. P.
    Duclos, M.
    Bratman, S.
    Swaminath, A.
    Warner, A.
    Palma, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (01): : E2 - E2
  • [4] Does Smoking Status Affect Survival After Chemoradiotherapy for Locally Advanced Non-SmallCell Lung Cancer?
    Wallace, N. D.
    Alexander, M.
    Xie, S.
    Ball, D.
    Solomon, B.
    Plumridge, N.
    Shaw, M.
    Harden, S.
    Hegi-Johnson, F.
    Siva, S.
    John, T.
    Officer, A.
    MacManus, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S105 - S106
  • [5] Optimal Cut-Off with NGS for Metamplification Andclinical Relevance to MET Inhibitor in Non-SmallCell Lung Cancer
    Liu, S. -Y. M.
    Xie, Z.
    Yan, L.
    Jie, G. -L.
    Deng, J. -Y.
    Zhang, Q.
    Huang, Z.
    Wang, J.
    Zhang, Z.
    Shao, Y.
    Meng, H.
    Zhang, Y.
    Zhang, X. -C.
    Zhong, W. -Z.
    Zhou, Q.
    Wu, Y. -L.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S172 - S173
  • [6] Proteomics-based identification of α-enolase as a tumor antigen in non-small lung cancer
    He, Ping
    Naka, Tetsuji
    Serada, Satoshi
    Fujimoto, Minoru
    Tanaka, Toshio
    Hashimoto, Shoji
    Shima, Yoshihito
    Yamadori, Tomoki
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Matsui, Kaoru
    Shiono, Hiroyuki
    Okumura, Meinoshin
    Nishida, Toshiro
    Tachibana, Isao
    Norioka, Naoko
    Norioka, Shigemi
    Kawase, Ichiro
    CANCER SCIENCE, 2007, 98 (08) : 1234 - 1240
  • [7] Predictive factors associated with prolonged survival in patients with advanced non-smallcell lung cancer (NSCLC) treated with gefitinib
    Satouchi, Miyako
    Funada, Yasuhiro
    Urata, Yoshiko
    Shimada, Temiko
    Yoshimura, Sho
    Watanabe, Hirokazu
    Kurata, Takayasu
    Adachi, Shuji
    Takada, Yoshiki
    Negoro, Shunichi
    ANNALS OF ONCOLOGY, 2006, 17 : 231 - 231
  • [8] Prognostic significance of K-ras point mutations in the serum of patients with advanced non-smallcell lung cancer
    Sirera, R
    Bayo, P
    Martin, M
    Safont, MJ
    Blasco, A
    Caballero, C
    Garde, J
    Berrocal, A
    Ponce, R
    Camps, C
    LUNG CANCER, 2004, 45 : S28 - S28
  • [9] Preoperative mediastinal staging in patients withcT1-3NxM0 non-smallcell lung cancer
    Steunenberg, Bastiaan E.
    Beddows, Tom P. A.
    De Groot, Hans G. W.
    Ayez, Ninos
    Van der Leest, Cor
    Aerts, Joachim G. J., V
    Veen, Eelco J.
    THORACIC CANCER, 2020, 11 (12) : 3456 - 3462
  • [10] Clinical Features and Prognostic Factors in Elderly Koreans with Advanced Non-SmallCell Lung Cancer in a Tertiary Referral Hospital
    Kim, Seo Woo
    Kim, Mi Yeon
    Lee, Yoon Pyo
    Ryu, Yon Ju
    Lee, Seok Jeong
    Lee, Jin Hwa
    Chang, Jung Hyun
    Shim, Sung Shine
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2013, 75 (02) : 52 - 58